相关实验视频

Updated: Jun 18, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

在胆道癌症中辅助化疗的网络元分析:为新的随机化证据奠定了基础

Francesca Salani^1,2, Guglielmo Vetere³, Daniele Rossini⁴

¹Translational Research and New Technologies in Medicine and Surgery Department, Pisa University, Pisa, Italy.

Liver international : official journal of the International Association for the Study of the Liver

|July 29, 2024

概括

辅助化疗改善了切除胆道癌症 (BTC) 的生存率. 皮里米丁,特别是皮,是最有效的治疗选择,提供显著的整体存活 (OS) 和无事件存活 (EFS) 益处.

科学领域:

在瘤学瘤学.
医学瘤学医学瘤学
临床试验临床试验

背景情况:

切除胆道癌症 (BTC) 的辅助化疗缺乏最佳治疗方案的明确证据.
建议使用capecitabine,但数据有限.
需要网络元分析来比较各种化疗方案.

研究的目的:

用网络元分析来比较不同辅助化疗方案对切除的BTC的疗效.
为了评估单一疗法 (gemcitabine,皮里米丁) 与观察和组合疗法.
根据整体存活率 (OS) 和无事件存活率 (EFS) 排名治疗方法.

主要方法:

在2023年12月之前对II/III期随机临床试验 (RCT) 进行系统的文献搜索.
频率主义随机效应模型用于估计OS和EFS的危险比率 (HRs).
使用直接和间接证据得出的P分数来排名治疗疗效.

主要成果:

分析了涉及1979名患者的6项RCT.
与观察相比,单独使用烯胺疗法显著改善了OS (HR 0.84) 和EFS (HR 0.79).
S1 显示了 OS (HR 0.69) 的优越性;皮里米丁和单疗法具有最好的 P 评分.

结论:

辅助化疗为切除的BTC患者提供了显著的OS和EFS益处.
甲胺,特别是甲,成为最有效的辅助治疗选择.
组合疗法没有显示出对单一疗法的优越性.

关键词:

辅助性化疗是一种辅助性化疗.胆道癌症胆道癌症胆道癌症网络元分析网络元分析预后预后预后

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...